NASDAQ: ACCD - Accolade, Inc.

Yield per half year: +66.43%
Sector: Healthcare

Company Analysis Accolade, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (6.83 $) is less than fair price (10.34 $)

Disadvantages

  • Dividends (0%) are below the sector average (0.5411%).
  • The stock's return over the last year (-43.29%) is lower than the sector average (-25.71%).
  • Current debt level 30.66% has increased over 5 years from 29.18%.
  • The company's current efficiency (ROE=-21.71%) is lower than the sector average (ROE=9.61%)

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Accolade, Inc. Healthcare Index
7 days 0% 1.9% 1.9%
90 days 116% -29.6% 7.6%
1 year -43.3% -25.7% 28.6%

ACCD vs Sector: Accolade, Inc. has significantly underperformed the "Healthcare" sector by -17.58% over the past year.

ACCD vs Market: Accolade, Inc. has significantly underperformed the market by -71.87% over the past year.

Slightly volatile price: ACCD is more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of about +/- 5-15% per week.

Long period: ACCD with weekly volatility of -0.8325% over the past year.

3. Summary of the report

3.1. General

P/E: 0
P/S: 1.93

3.2. Revenue

EPS -1.33
ROE -21.71%
ROA -11.8%
ROIC -12.75%
Ebitda margin -17.18%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (6.83 $) is lower than the fair price (10.34 $).

Price significantly below the fair price: The current price (6.83 $) is 51.4% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (48.73).

P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (49.04).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.8) is lower than that of the sector as a whole (4.83).

P/BV vs Market: The company's P/BV (1.8) is lower than that of the market as a whole (3.17).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (1.93) is lower than that of the sector as a whole (33.76).

P/S vs Market: The company's P/S indicator (1.93) is lower than that of the market as a whole (10.24).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (-12.02) is higher than that of the sector as a whole (-22.19).

EV/Ebitda vs Market: The company's EV/Ebitda (-12.02) is lower than that of the market as a whole (28.32).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 18.83% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (18.83%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (4135.44%).

5.4. ROE

ROE vs Sector: The company's ROE (-21.71%) is lower than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (-21.71%) is lower than that of the market as a whole (10.71%).

5.5. ROA

ROA vs Sector: The company's ROA (-11.8%) is lower than that of the sector as a whole (0.3443%).

ROA vs Market: The company's ROA (-11.8%) is lower than that of the market as a whole (6.47%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (-12.75%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (-12.75%) is lower than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (30.66%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 29.18% to 30.66%.

Excess of debt: The debt is not covered by net income, percentage -242.12%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.5411%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 7.52% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
17.01.2025 Cavanaugh Robert N
Officer
Purchase 6.86 1 276 186
17.01.2025 SINGH RAJEEV
Officer
Purchase 6.86 2 120 309
17.01.2025 Barnes Stephen H.
Officer
Purchase 6.86 1 056 154
13.01.2025 SINGH RAJEEV
Officer
Purchase 6.88 3 722 541
13.01.2025 Cavanaugh Robert N
Officer
Purchase 6.88 1 761 256

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Accolade, Inc.

9.3. Comments